Crossmark

Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)–Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study

Crossref DOI link: https://doi.org/10.1007/s00270-022-03141-y

Published Online: 2022-04-11

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ouyang, Tao

Cao, Yanyan

Chen, Lei

Zheng, Chuansheng
Funding

Funding for this research was provided by:

The National Natural Science Foundation of China (81873919)
License Information

Text and Data Mining valid from 2022-04-11

Version of Record valid from 2022-04-11
More Information

Article History

Received: 9 September 2021

Accepted: 28 March 2022

First Online: 11 April 2022

Declarations

:

: There is no conflict of interest in this manuscript, and the manuscript has been approved for publication by all authors.

Document is current

Any future updates will be listed below